Study of Metabolic Content of Urine

NCT ID: NCT05637840

Last Updated: 2024-02-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-06

Study Completion Date

2023-11-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to test the different components in urine and see if they can be matched to food, exercise and sleep that participants report. The researchers are trying to find out if urine would allow them to predict medical problems as they are happening. Participants are healthy volunteers who are willing to give urine samples on a daily basis, and can expect to be in the study for 28 days.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this research study is to analyze urine samples using Mass Spectrometry to identify metabolites that have the potential to be used for medical diagnosis. This data, along with data from wearable devices, will be combined and analyzed to correlate what an individual does on a daily basis with how their body metabolizes their choices. This type of data may provide insights into the origins and progression of diseases in a short time span.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Content of Urine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sleep limited

Participants will be asked to limit their sleep

Group Type EXPERIMENTAL

Urine sample

Intervention Type OTHER

Collection of 36-84 urine samples over a 14 consecutive day period.

Sleep restriction

Intervention Type OTHER

Participants will be asked to limit their sleep to 4 hours within a 24-hour period for 2 days in a row.

No sleep limitation

Participants will be asked to get their normal amount of sleep.

Group Type EXPERIMENTAL

Urine sample

Intervention Type OTHER

Collection of 36-84 urine samples over a 14 consecutive day period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Urine sample

Collection of 36-84 urine samples over a 14 consecutive day period.

Intervention Type OTHER

Sleep restriction

Participants will be asked to limit their sleep to 4 hours within a 24-hour period for 2 days in a row.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be 18 years or older
* Be able to provide informed consent
* Stated willingness to comply with all study procedures and have availability for the duration of the study

Exclusion Criteria

* Presence of a condition(s) or diagnosis, either physical or psychological, that limits the ability to urinate in the collection apparatus
* Individuals who do not consistently get at least 6 hours of sleep per night
* Individuals who have a sleep disorder diagnosis.
* Individuals who live in the state of New York
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Morgridge Institute for Research

UNKNOWN

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joshua Coon, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wisconsin

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A537700

Identifier Type: OTHER

Identifier Source: secondary_id

SMPH/BIOMOLEC CHEM/BIOMOL CHM

Identifier Type: OTHER

Identifier Source: secondary_id

Protocol Version 9/28/22

Identifier Type: OTHER

Identifier Source: secondary_id

2022-1111

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Urodynamics: Prone Vs. Seated Position
NCT06864117 NOT_YET_RECRUITING NA